E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
AI offers an opportunity to strengthen radiology by reducing workflow burdens, improving prioritisation of critical cases, and enabling faster clinical decision-making.
imphoenix82
The WHO-sponsored study in the Democratic Republic of the Congo will evaluate monoclonal antibody MBP134 and remdesivir as potential therapies for Bundibugyo virus disease.
imphoenix82
The newly listed test detects Bundibugyo virus by identifying its genetic material in blood samples, enabling rapid and accurate confirmation of infection.
imphoenix82
Patients and healthcare providers are advised not to use any DARZALEX products bearing batch numbers MYS7381 or STV1K01.
imphoenix82
SK bioscience, PATH, Slalom, and SK AX are developing an AI-powered platform under the Gates Foundation-funded ROTOR project to advance rotavirus vaccine development and improve vaccine access in LMICs.
imphoenix82
The US FDA inspected Lupin’s manufacturing facility in Somerset, New Jersey, from April 13 to April 17, 2026.
imphoenix82
Rising GERD prevalence, increasing adoption of reflux diagnostic tools, growing demand for minimally invasive anti-reflux procedures, and expanding hospital endoscopy infrastructure are driving growth in the global GERD device market.
imphoenix82
The partnership between Suzhou Ribo Life Science and Madrigal Pharmaceuticals focuses on developing RNA-based therapeutics for metabolic dysfunction-associated steatohepatitis (MASH).
imphoenix82
Under the agreement, Insilico will lead the AI-driven discovery process to identify molecules that meet predefined scientific and early development criteria, while Takeda will leverage its global development capabilities to advance selected candidates through clinical validation.
imphoenix82
The transfer was executed on a slump sale basis in accordance with the Business Transfer Agreement (BTA) signed between Aurobindo Pharma and Auropharm.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
